Conference Reports for NATAP
19th Conference on Retroviruses and
Opportunistic Infections
Seattle, WA March 5 - 8, 2012
Back
 
Dolutegravir ViiV Integrase Inhibitor phase 2b SPRING Study 96-Week Results in Treatment-Naives
Reported by Jules Levin
19th CROI March 5-8 2012 Seattle, WA